Most recently acquired 46,730 shares in Dec 2016. Currently holds stock worth $170.60K.
Compensation History
Annual executive compensation data for Alexander Tokman, including salary, bonuses, and stock awards.
Year
2017
Total Compensation
$0.00
Salary
$0.00
Bonus
$0.00
Other
$0.00
Salary
$0.00Board Justification
The company aims to align compensation with performance metrics and market standards, but specific details for 2017 were not provided.
Bonus
$0.00Board Justification
No bonus was reported for the year 2017.
Other Compensation
$0.00Board Justification
No other compensation was reported for the year 2017.
Restricted Stock
Board Justification
No stock was reported as vested in 2017.
Performance Metrics
Performance metrics for compensation were not disclosed in the proxy statement.
Alexander Tokman
CEO of ENDRA Life Sciences Inc.
Sector of Economy
Healthcare
CEO of ENDRA Life Sciences Inc. for
0 years 4 months (Jul 2025 - Present)
Previous Experience
Unknown
Other ENDRA Life Sciences Inc. CEOs
Holdings
Track Alexander Tokman's stock holdings and portfolio value over time.
Insider Trading
Alexander Tokman's recent stock transactions, purchases, and sales filed with the SEC.
$50.00K
MVIS at $1.07/share
Dec 14, 2016
Purchase
5,785 shares
MVIS
Jun 1, 2016
Received
$23.35K
MVIS at $2.33/share
Nov 13, 2015
Purchase
6,129 shares
MVIS
Jun 3, 2014
Received
$12.69K
MVIS at $1.27/share
Dec 5, 2013
Purchase
$27.00K
MVIS at $1.35/share
Nov 19, 2013
Purchase
60,746 shares
MVIS
Aug 8, 2013
Received
$9.80K
MVIS at $0.39/share
Dec 9, 2011
Purchase
$7.06K
MVIS at $0.47/share
Nov 16, 2011
Purchase
$9.21K
MVIS at $0.92/share
Sep 8, 2011
Purchase
Rivals
Compare Alexander Tokman with competitor CEOs and industry peers.